ACCESS TO
MEDICINES
In 2016, the fight for universal access to medicines continued to be one of our fundamental cornerstones. Our work, which focuses on a change in the pharmaceutical innovation and development model, has been expanded through our actions and those undertaken by No Es Sano, a campaign we’ve promoted which features the participation of some twenty different organisations. Moreover, we’ve actively participated in European and international political process relating to medication access and scientific policy, largely written into Horizon 2020. We’ve worked with various stakeholders from the European Alliance for Responsible R+D and Affordable Medicines to other networks such as HAI, EPHA and EACH Group /GHA.